Skip to content

LivaNova LIVN Interest Income

Interest Income at other companies

Abbott logo
AbbottABT
$106M+29.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$3.9M+2.9%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$6.91M-14.5%
Nordson logo
NordsonNDSN
$362K-34.5%
Edwards Lifesciences logo
Edwards LifesciencesEW
$33.5M-8.2%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's interest income?
LivaNova (LIVN) reported interest income of $3.55M in Q1 2026.
How has LivaNova's interest income changed year-over-year?
LivaNova's interest income decreased by 44.9% year-over-year, from $6.44M to $3.55M.
What is the long-term trend for LivaNova's interest income?
Over 4 years (2021 to 2025), LivaNova's interest income has grown at a 147.1% compound annual growth rate (CAGR), from $509K to $18.98M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.